Results 121 to 130 of about 814,420 (203)

Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis. [PDF]

J Allergy Clin Immunol
Sharlin CS, Yamada S, Maekawa Y, Osonoi K, Matsuyama K, Osswald GA, Rochman M, Taylor RJ, Yamaguchi M, Tanaka Y, Wen T, Dellon ES, Rothenberg ME, Shoda T.   +13 more
europepmc   +1 more source

Patients' perception of proton pump inhibitors use and their risks. [PDF]

World J Clin Oncol
Sawaied IO, Samson AO, Golan E.
europepmc   +1 more source

Proton pump inhibitor use and long-term outcomes in SSc: a real-life analysis from the EUSTAR database. [PDF]

Rheumatology (Oxford)
Bonomi F, Bandini G, Campochiaro C, De Silvestri V, Agachi S, Bergmann C, Distler O, Granel B, Henes J, Iannone F, Idolazzi L, Kerzberg E, Naffaa ME, Poormoghim H, Radic M, Truchetet ME, Bellando Randone S, Matucci Cerinic M, McMahan ZH, Hughes M, EUSTAR Group .   +20 more
europepmc   +1 more source

Comparative Reporting Patterns of Rabeprazole and Other Proton Pump Inhibitors in EudraVigilance: A System Organ Class-Level Disproportionality Analysis. [PDF]

J Xenobiot
Moleriu RD, Cioacă GR, Muntean C, Ilie AC, Vlad DC, Piroș T, Marin RC.   +6 more
europepmc   +1 more source

Evolution of proton pump inhibitor research in reflux esophagitis: a Web of Science-based global bibliometric assessment [1990-2026]. [PDF]

J Thorac Dis
Wang Y, Wang R, Wang T, Zhao Y, Ju X.
europepmc   +1 more source

Posterior Reversible Encephalopathy Syndrome Associated With Severe Proton Pump Inhibitor-Induced Hypomagnesemia: A Rare Case. [PDF]

Cureus
Ciampa C, Antenora A, Salzano C, Apuzzi V, Bassi V.   +4 more
europepmc   +1 more source

High Potency Proton Pump Inhibitor Versus Vonoprazan in Helicobacter pylori Triple Therapy. [PDF]

Helicobacter
Tan MC, Atmar RL, Graham DY.
europepmc   +1 more source